Anrukinzumab (IMA-638) is a humanized anti-IL-13 моноклональный антитело. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma.
Anrukinzumab (IMA-638) is a humanized anti-IL-13 monoclonal antibody. Anrukinzumab effectively reduces lung inflammation in a cynomolgus monkey model. Anrukinzumab can be used in studies of ulcerative colitis (UC) as well as asthma.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.